Market Tracker

08/22 6:05pm ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

8.40
Data as of Aug 22
 +0.24 / +2.94%
Today’s Change
1.68
Today|||52-Week Range
9.56
+233.33%
Year-to-Date
Traders Are Staying Active
Aug 20 / TheStreet.com
Morning Market Movers
Aug 20 / Benzinga
The Fed Is Already Old News
Aug 20 / TheStreet.com
Still a Buyer
Aug 20 / TheStreet.com

Today’s Trading

Previous close8.16
Today’s open8.12
Day’s range8.01 - 8.44
Volume330,984
Average volume (3 months)570,324
Market cap$310.4M
Dividend yield--
Data as of 3:59pm ET, 08/22/2014

Growth & Valuation

Earnings growth (last year)-1,300.00%
Earnings growth (this year)+47.86%
Earnings growth (next 5 years)+3.90%
Revenue growth (last year)+38.43%
P/E ratioNM
Price/Sales1.08
Price/Book2.74

Competitors

 Today’s
change
Today’s
% change
TGTXTG Therapeutics Inc-0.01-0.12%
XNCRXencor Inc+0.41+4.17%
ADMSAdamas Pharmaceutica...-0.54-2.94%
SVASinovac Biotech Ltd+0.06+1.08%
Data as of 3:59pm ET, 08/22/2014

Financials

Next reporting dateNovember 18, 2014
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$84.9M
Annual profit (last year)-$25.6M
Net profit margin-30.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman, President &
Chief Executive Officer
Douglas L. Drysdale
Chief Operating Officer
Terence S. Novak
Corporate headquarters
Morristown, New Jersey

Forecasts